PL378344A1 - Sposób usprawniania przepływu krwi - Google Patents

Sposób usprawniania przepływu krwi

Info

Publication number
PL378344A1
PL378344A1 PL378344A PL37834403A PL378344A1 PL 378344 A1 PL378344 A1 PL 378344A1 PL 378344 A PL378344 A PL 378344A PL 37834403 A PL37834403 A PL 37834403A PL 378344 A1 PL378344 A1 PL 378344A1
Authority
PL
Poland
Prior art keywords
blood circulation
improvement
enhancement
pharmaceutical
person
Prior art date
Application number
PL378344A
Other languages
English (en)
Other versions
PL215868B1 (pl
Inventor
Anke Esperester
Eckhard Schaefer
Fritz Sacher
Holger Kiesewetter
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL378344A1 publication Critical patent/PL378344A1/pl
Publication of PL215868B1 publication Critical patent/PL215868B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
PL378344A 2002-12-31 2003-12-12 Zastosowanie lecznicze kompozycji zawierajacej wodny ekstrakt z lisci czerwonej winorosli PL215868B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02029107A EP1435242A1 (en) 2002-12-31 2002-12-31 Method of improvement of blood circulation

Publications (2)

Publication Number Publication Date
PL378344A1 true PL378344A1 (pl) 2006-03-20
PL215868B1 PL215868B1 (pl) 2014-02-28

Family

ID=32479738

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378344A PL215868B1 (pl) 2002-12-31 2003-12-12 Zastosowanie lecznicze kompozycji zawierajacej wodny ekstrakt z lisci czerwonej winorosli

Country Status (18)

Country Link
EP (2) EP1435242A1 (pl)
JP (1) JP2006516542A (pl)
AT (1) ATE545426T1 (pl)
AU (1) AU2003290031A1 (pl)
BR (1) BR0317895A (pl)
CA (1) CA2512147C (pl)
CY (1) CY1112766T1 (pl)
DK (1) DK1581239T3 (pl)
ES (1) ES2382461T3 (pl)
MX (1) MXPA05007095A (pl)
PE (1) PE20040932A1 (pl)
PL (1) PL215868B1 (pl)
PT (1) PT1581239E (pl)
RU (1) RU2341280C2 (pl)
SI (1) SI1581239T1 (pl)
TW (1) TW200501973A (pl)
UA (1) UA85548C2 (pl)
WO (1) WO2004058280A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049796A2 (en) 2005-10-26 2007-05-03 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
MX2010001693A (es) * 2007-08-31 2010-03-11 Boehringer Ingelheim Int Composicion pulverizable que contiene extracto de hojas de parra rojas.
DE102008012908A1 (de) 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
JP2015224205A (ja) 2014-05-27 2015-12-14 エスエス製薬株式会社 冷え症等の全身症状改善用経口組成物
KR20200115927A (ko) * 2019-03-29 2020-10-08 주식회사 유니베라 포도잎 추출물 및 병풀 추출물을 포함하는 정맥순환 장애 개선용 조성물
JP7262079B2 (ja) * 2019-06-27 2023-04-21 廉士 澤田 生体センサ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278161A (pl) * 1961-05-13
FR2276059A1 (fr) * 1974-06-25 1976-01-23 Agronomique Inst Nat Rech Procede d'extraction de pigments vegetaux de la classe des facteurs vitaminiques p a partir de plantes en contenant
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤

Also Published As

Publication number Publication date
EP1581239B1 (en) 2012-02-15
WO2004058280A1 (en) 2004-07-15
CY1112766T1 (el) 2016-02-10
MXPA05007095A (es) 2005-09-12
PL215868B1 (pl) 2014-02-28
PT1581239E (pt) 2012-05-11
SI1581239T1 (sl) 2012-06-29
CA2512147C (en) 2014-09-16
DK1581239T3 (da) 2012-06-11
UA85548C2 (ru) 2009-02-10
ATE545426T1 (de) 2012-03-15
JP2006516542A (ja) 2006-07-06
CA2512147A1 (en) 2004-07-15
ES2382461T3 (es) 2012-06-08
EP1581239A1 (en) 2005-10-05
PE20040932A1 (es) 2004-12-31
TW200501973A (en) 2005-01-16
BR0317895A (pt) 2005-12-06
RU2341280C2 (ru) 2008-12-20
EP1435242A1 (en) 2004-07-07
AU2003290031A1 (en) 2004-07-22
RU2005124164A (ru) 2006-03-20

Similar Documents

Publication Publication Date Title
SI1594833T1 (sl) Derivati 1-fenilalkankarboksilne kisline za zdravljenje nevrodegenerativnih bolezni
NO20042150L (no) Naeringsmiddel- eller dyrefôrsammensetning som innheholder planteekstrakt for benhelsen
CY1112766T1 (el) Εγκαιρη χρηση ενος εκχυλισματος απο φυλλα κοκκινης ποικιλιας αμπελου
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
PT2194049E (pt) N-óxidos de derivados de n-fenil-2-pirimidina-amina
SI2298338T1 (sl) Laktoferinski sestavki in postopki za zdravljenjekožnih ran
NO20062355L (no) Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
IL149134A0 (en) Pharmaceutical compositions containing tofisopam
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
TW200719908A (en) Dermatologic use of milk proteins
WO2004110373A3 (en) Therapeutic vaccine compositions for the treatment of type 1 diabetes
BR0208554A (pt) Osteoprotegerina no leite
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
DE69804466D1 (de) Robinia pseudoacacia lektin und seine verwendungen
AR042682A1 (es) Metodo que mejora la circulacion sanguinea administrando una composicion que contiene un extracto acuoso de hojas de parra roja
ATE404519T1 (de) Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
WO2006127759A3 (en) Antioxidant supplement composition and method of use
ITRM20010494A1 (it) Integratore dietetico per la cura e la prevenzione della miopia.
BG106025U (en) Medicamentous form
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.
NZ512402A (en) Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
UA34283A (uk) Спосіб діагностики порушень імунологічного статусу у людини та тварин
UA36561A (uk) Спосіб лікування гіпертонічної хвороби методом нормобаричної гіпоксичної терапії